Performance status -3 - Symptomatic, 50 in bed Posts on Medivizor
Navigation Menu

Performance status -3 – Symptomatic, 50 in bed Posts on Medivizor

Treating chronic lymphocytic leukemia/small lymphocytic lymphoma with rituximab and high-dose methylprednisolone

Treating chronic lymphocytic leukemia/small lymphocytic lymphoma with rituximab and high-dose methylprednisolone

Posted by on Feb 6, 2022 in Leukemia | 0 comments

In a nutshell This study aimed to investigate using rituximab (Rituxan) and high-dose methylprednisolone (HDMP; Medrol) as a treatment for chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL).   This study concluded that this treatment is a good option for elderly and frail patients and can work as a bridge to...

Read More

Looking for patients with relapsed or unresponsive acute myeloid leukemia to test a new targeted therapy drug

Posted by on Jul 23, 2019 in Leukemia | 0 comments

In a nutshell This trial is examining the effectiveness of crenolanib after salvage chemotherapy for relapsed or unresponsive acute myeloid leukemia (AML) with FLT3 activating mutations. The main outcome would be survival without complications from leukemia 3 years after the treatment has finished. The details AML is a type of blood...

Read More

Searching for newly diagnosed patients with B-lineage acute lymphoblastic leukemia to participate in a randomized immunotherapy trial

Posted by on Sep 11, 2017 in Leukemia | 0 comments

In a nutshell This phase 3 clinical trial will test the effectiveness of blinatumomab (Blincyto) with chemotherapy versus chemotherapy alone in treating patients with newly diagnosed B lineage acute lymphoblastic leukemia (ALL) that is BCR-ABL negative. The primary outcome will be measured by the overall survival. The details Blinatumomab is...

Read More